Glaukos (GKOS) Non-Current Assets (2014 - 2026)
Glaukos (GKOS) posted quarterly Non-Current Assets of $404.7 million for Q2 2026, down 26.53% year-over-year from $550.9 million in Q2 2025, and down 0.69% quarter-over-quarter from $407.6 million in Q1 2026.
Glaukos (GKOS) Non-Current Assets (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Non-Current Assets for 13 consecutive years, with $404.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 26.53% year-over-year to $404.7 million; the TTM figure through Jun 2026 stood at $1.8 billion (down 16.52% YoY), while the FY2025 annual figure was $418.5 million, down 20.28% from the prior year.
- Non-Current Assets retreated to $404.7 million in Q2 2026 per GKOS's latest filing, from $407.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $560.9 million in Q1 2022 and bottomed at $404.7 million in Q2 2026.
- Historically, Non-Current Assets has averaged $523.8 million across 5 years, with a median of $544.8 million in 2023.
- Annual changes were most pronounced in 2025 — Non-Current Assets rose 2.9% — and 2026, when it slipped 26.53%.
- Glaukos' Non-Current Assets stood at $558.5 million in 2022, then declined by 2.43% to $545.0 million in 2023, then declined by 3.67% to $525.0 million in 2024, then declined by 20.28% to $418.5 million in 2025, then retreated by 3.29% to $404.7 million in 2026.
- Business Quant data shows GKOS's Non-Current Assets at $404.7 million in Q2 2026, $407.6 million in Q1 2026, and $418.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | 404.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 404.74 Mn |
| Mar 31, 2026 | 407.57 Mn |
| Dec 31, 2025 | 418.50 Mn |
| Sep 30, 2025 | 544.61 Mn |
| Jun 30, 2025 | 550.89 Mn |
| Mar 31, 2025 | 521.63 Mn |
| Dec 31, 2024 | 524.96 Mn |
| Sep 30, 2024 | 529.26 Mn |
| Jun 30, 2024 | 535.89 Mn |
| Mar 31, 2024 | 544.73 Mn |
| Dec 31, 2023 | 544.95 Mn |
| Sep 30, 2023 | 549.11 Mn |
| Jun 30, 2023 | 555.48 Mn |
| Mar 31, 2023 | 556.71 Mn |
| Dec 31, 2022 | 558.52 Mn |
| Sep 30, 2022 | 559.63 Mn |
| Jun 30, 2022 | 560.18 Mn |
| Mar 31, 2022 | 560.87 Mn |
| Dec 31, 2021 | 563.57 Mn |
| Sep 30, 2021 | 562.32 Mn |